MX2020013306A - Uso de compuestos de halogeno para el tratamiento y prevencion de lesiones tisulares y sindrome post-cuidados intensivos. - Google Patents
Uso de compuestos de halogeno para el tratamiento y prevencion de lesiones tisulares y sindrome post-cuidados intensivos.Info
- Publication number
- MX2020013306A MX2020013306A MX2020013306A MX2020013306A MX2020013306A MX 2020013306 A MX2020013306 A MX 2020013306A MX 2020013306 A MX2020013306 A MX 2020013306A MX 2020013306 A MX2020013306 A MX 2020013306A MX 2020013306 A MX2020013306 A MX 2020013306A
- Authority
- MX
- Mexico
- Prior art keywords
- intensive care
- post
- halogen compounds
- prevention
- treatment
- Prior art date
Links
- 150000002366 halogen compounds Chemical class 0.000 title abstract 2
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 208000037816 tissue injury Diseases 0.000 title 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- -1 iodide Chemical class 0.000 abstract 1
- 210000002027 skeletal muscle Anatomy 0.000 abstract 1
- 230000000451 tissue damage Effects 0.000 abstract 1
- 231100000827 tissue damage Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862682574P | 2018-06-08 | 2018-06-08 | |
| US201862730927P | 2018-09-13 | 2018-09-13 | |
| US201862730945P | 2018-09-13 | 2018-09-13 | |
| PCT/US2019/036154 WO2019237065A1 (en) | 2018-06-08 | 2019-06-07 | Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020013306A true MX2020013306A (es) | 2021-05-12 |
Family
ID=68770655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020013306A MX2020013306A (es) | 2018-06-08 | 2019-06-07 | Uso de compuestos de halogeno para el tratamiento y prevencion de lesiones tisulares y sindrome post-cuidados intensivos. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210252047A1 (enExample) |
| EP (1) | EP3801565A4 (enExample) |
| JP (1) | JP2021527130A (enExample) |
| KR (1) | KR20210018898A (enExample) |
| CN (1) | CN112469422A (enExample) |
| AU (1) | AU2019282820A1 (enExample) |
| CA (1) | CA3102792A1 (enExample) |
| IL (1) | IL279221A (enExample) |
| MX (1) | MX2020013306A (enExample) |
| WO (1) | WO2019237065A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3104939T3 (pl) | 2014-02-10 | 2024-09-30 | Fred Hutchinson Cancer Center | Leczenie jodkiem sodu zawału serca i urazu niedokrwiennego |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248335B1 (en) * | 1997-10-29 | 2001-06-19 | Symbollon Corporation | Stabilized oral pharmaceutical composition containing iodide and iodate and method |
| CZ295765B6 (cs) * | 1998-07-29 | 2005-10-12 | Apa - Praha, S.R.O. | Léčebný přípravek s virucidním účinkem |
| GB0525504D0 (en) * | 2005-12-14 | 2006-01-25 | Bristol Myers Squibb Co | Antimicrobial composition |
| PL3104939T3 (pl) * | 2014-02-10 | 2024-09-30 | Fred Hutchinson Cancer Center | Leczenie jodkiem sodu zawału serca i urazu niedokrwiennego |
-
2019
- 2019-06-07 EP EP19814153.3A patent/EP3801565A4/en not_active Withdrawn
- 2019-06-07 CN CN201980049776.3A patent/CN112469422A/zh active Pending
- 2019-06-07 JP JP2021518059A patent/JP2021527130A/ja active Pending
- 2019-06-07 MX MX2020013306A patent/MX2020013306A/es unknown
- 2019-06-07 CA CA3102792A patent/CA3102792A1/en active Pending
- 2019-06-07 AU AU2019282820A patent/AU2019282820A1/en not_active Abandoned
- 2019-06-07 WO PCT/US2019/036154 patent/WO2019237065A1/en not_active Ceased
- 2019-06-07 US US16/972,718 patent/US20210252047A1/en not_active Abandoned
- 2019-06-07 KR KR1020217000098A patent/KR20210018898A/ko not_active Ceased
-
2020
- 2020-12-06 IL IL279221A patent/IL279221A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL279221A (en) | 2021-01-31 |
| JP2021527130A (ja) | 2021-10-11 |
| KR20210018898A (ko) | 2021-02-18 |
| EP3801565A1 (en) | 2021-04-14 |
| AU2019282820A1 (en) | 2021-01-21 |
| WO2019237065A1 (en) | 2019-12-12 |
| CA3102792A1 (en) | 2019-12-12 |
| EP3801565A4 (en) | 2022-04-06 |
| US20210252047A1 (en) | 2021-08-19 |
| CN112469422A (zh) | 2021-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285782A (en) | Compounds, compositions, and methods for treating disease | |
| WO2018022668A3 (en) | NEUROMODULATORY COMPOSITIONS AND ASSOCIATED METHODS OF TREATING CANCER | |
| IL276398A (en) | Combined treatment for mastocytosis | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| MX2020001774A (es) | Composiciones y métodos para tratar enfermedad colestásica. | |
| MX387115B (es) | Métodos para tratar la influenza. | |
| MY198928A (en) | B7-h3 antibody, antigen-binding fragment thereof and medical use thereof | |
| NZ721500A (en) | Use of halogen compounds for the treatment and prevention of heart attack and ischemic injury | |
| MX389927B (es) | Metodos de tratamiento del sindrome de lennox-gastaut con fenfluramina. | |
| MX2019009753A (es) | Composicion y metodos para prevenir lesion por radiacion y promover la regeneracion de tejidos. | |
| HK1253734A1 (zh) | 用作RORγ激动剂和用於治疗疾病的芳基二氢-2H-苯并[B][1，4]恶嗪磺酰胺和相关化合物 | |
| SI3700529T1 (sl) | Nova kombinacija zdravilnih učinkovin za zdravljenje progresivnih fibroznih intersticijskih pljučnih bolezni (PF-ILD) | |
| MX2022007285A (es) | Compuestos, polimeros, dispositivos y usos de los mismos. | |
| ZA201705874B (en) | Nk-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat | |
| WO2016004413A3 (en) | Gls1 inhibitors for treating disease | |
| EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
| WO2016029136A8 (en) | 3-amidobenzamides and uses thereof for increasing cellular levels of a3g | |
| PH12020551179A1 (en) | Methods for treating mitochondrial disorder | |
| EP4000609A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES | |
| MX2020001164A (es) | Composicion para su uso en la prevencion y/o el tratamiento de la mucositis orogastrointestinal inducida por un tratamiento oncologico. | |
| KR102177130B9 (ko) | 근육 질환 및 신경근육 질환 예방, 치료 또는 진단을 위한 miR-18b의 용도 | |
| PH12021550121A1 (en) | Methods of treating hfpef employing dapagliflozin and compositions comprising the same | |
| EP3946433A4 (en) | COMPOSITIONS, DEVICES AND METHODS FOR TREATMENT OF FABRY DISEASE | |
| MX2020013100A (es) | Metodos de uso de cd24 para la prevencion y tratamiento de enfermedad de injerto contra hospedero y mucositis. | |
| GEP20207136B (en) | Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition |